Publication | Open Access

Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trial

ThrombosisSickle Cell AnaemiaIschemic StrokePediatric EpidemiologyStrokeGlobal HealthDose EscalationClinical EpidemiologyHematologyPediatric HematologyCerebrovascular DiseaseStroke-related ConditionPublic HealthMedicine